Q3 2024 Earnings Forecast for Enanta Pharmaceuticals, Inc. Issued By HC Wainwright (NASDAQ:ENTA)

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) – Equities research analysts at HC Wainwright lowered their Q3 2024 earnings per share (EPS) estimates for shares of Enanta Pharmaceuticals in a research note issued to investors on Tuesday, May 7th. HC Wainwright analyst E. Arce now anticipates that the biotechnology company will post earnings of ($1.48) […]

Leave a Reply

Your email address will not be published.

Previous post Sidoti Csr Weighs in on Lee Enterprises, Incorporated’s Q3 2024 Earnings (NYSE:LEE)
Next post B. Riley Comments on Genius Sports Limited’s Q3 2024 Earnings (NYSE:GENI)